Ovid Therapeutics

OVID

Börsenwert 547 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	9,8 Mio. $	-718.475 $	-88.807	-6 %
2	2 BlackRock New York	9,6 Mio. $	+2,39 Mio. $	+295.247	+28 %
3	3 Jennison Associates New York	4,6 Mio. $	+587.768 $	+72.651	+13 %
4	4 Tekla Capital Management Boston, Massachusetts	3,79 Mio. $	–	–	–
5	5 OppenheimerFunds New York	3 Mio. $	-4.450 $	-550	-0,1 %
6	6 Vanguard Group Malvern, Pennsylvania	2,83 Mio. $	+537.714 $	+66.464	+20 %
7	7 T. Rowe Price Associates Baltimore, Maryland	2,12 Mio. $	+7.362 $	+910	+0,3 %
8	8 Deutsche Bank Frankfurt Am Main Ge, Germany	2,09 Mio. $	+684.609 $	+84.621	+40 %
9	9 Driehaus Capital Management Chicago, Illinois	2,01 Mio. $	+98.872 $	+12.221	+4 %
10	BBA 10 Baker Bros. Advisors New York	1,75 Mio. $	-692.530 $	-85.600	-26 %
11	11 Ameriprise Minneapolis, Minnesota	1,47 Mio. $	-63.064 $	-7.795	-4 %
12	12 Redmile Group San Francisco, California	1,14 Mio. $	-1,23 Mio. $	-152.064	-49 %
13	13 Northern Trust Chicago, Illinois	837.000 $	+430.922 $	+53.264	+82 %
14	14 Bridgeway Capital Management Houston, Texas	767.000 $	+480.887 $	+59.440	+121 %
15	15 State Street Boston, Massachusetts	747.000 $	+244.020 $	+30.162	+40 %
16	16 Millennium Management New York	420.000 $	+480.111 $	+59.344	Neu
17	17 Geode Capital Management Boston, Massachusetts	353.000 $	+130.011 $	+16.070	+47 %
18	18 Charles Schwab San Francisco, California	243.000 $	+111.525 $	+13.785	+67 %
19	19 JP Morgan Chase New York	233.000 $	+221.213 $	+27.343	+483 %
20	20 Morgan Stanley New York	196.000 $	+8.204 $	+1.014	+4 %
21	21 Bank of New York Mellon New York	180.000 $	+96.186 $	+11.889	+88 %
22	22 Schonfeld Strategic Advisors New York	145.000 $	–	–	–
23	23 Spark Investment Management New York	139.000 $	+72.813 $	+9.000	+83 %
24	24 California State Teachers Retirement System (CalSTRS) West Sacramento, California	132.000 $	+79.091 $	+9.776	+110 %
25	25 TIAA CREF Investment Management New York	119.000 $	–	–	–

Ovid Therapeutics OVID Börsenwert 547 Mio. $

Ovid Therapeutics

OVID

Börsenwert 547 Mio. $